Skip to main content

thirty madison

By October 25, 2018Headlines1 min read

You will be pleased to know that Thirty Madison is rebuilding the health care experience for modern consumers and apparently is also fleecing modern investors, acquiring $15.25 million in new financing to create a platform to treat chronic conditions, although their primary product to date has been one that addresses baldness.  Hope investors don’t take a haircut.

Kevin Roche

Author Kevin Roche

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com.

More posts by Kevin Roche

Leave a comment